Matthew is a postdoctoral research associate who completed his British Heart Foundation-funded PhD in 2023 investigating inflammageing and sinoatrial node disease. He is trained in a wide variety of electrophysiology (in vivo/ex vivo), biochemistry and molecular biology techniques. Matthew has published in journals including Nature Scientific Reports, Circulation Research, and Cardiovascular Research.
After a brief PDRA role at Imperial College London, Matthew has moved to the Microvascular group to develop skills in single-cell electrophysiology with Dr Harry Pritchard and Professor Adam Greenstein. Initially, Matthew is investigating the effect of sepsis and reactive oxygen species on mesenteric artery smooth muscle cells in collaboration with Dr Christopher Stanley of the Microvascular Research Unit (Heart Research Institute, University of Sydney).
Additionally, Matthew is currently developing a project to investigate cardiovascular coupling – the coupling between coronary arteries and cardiac myocytes. This will combine Matthew’s background in heart research and his (developing) microvascular and single-cell electrophysiology techniques.
Microvascular @ Manchester 